G Krishna Gorti

J.P. Morgan analysts Geoffrey Meacham, Terrance P Coyne, G Krishna Gorti and Michael E Ulz maintained their Overweight rating for shares of Gilead Sciences, Inc (Nasdaq: GILD), with a price target of $55 per share. The analysts said they still like the stock, which is valued at a near worst-case...